Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BI-4464

Copy Product Info
😃Good
Catalog No. T5480Cas No. 1227948-02-8

BI-4464, a highly selective ATP-competitive inhibitor of PTK2/FAK, exhibits an IC50 of 17 nM and serves as a PTK2 ligand for PROTAC (Proteolysis Targeting Chimera).

BI-4464

BI-4464

Copy Product Info
😃Good
Purity: 99.81%
Catalog No. T5480Cas No. 1227948-02-8
BI-4464, a highly selective ATP-competitive inhibitor of PTK2/FAK, exhibits an IC50 of 17 nM and serves as a PTK2 ligand for PROTAC (Proteolysis Targeting Chimera).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$31In StockIn Stock
5 mg$74In StockIn Stock
10 mg$118In StockIn Stock
25 mg$213In StockIn Stock
50 mg$322In StockIn Stock
100 mg$449In StockIn Stock
200 mg$633-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.81%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

BI-4464 AI Summary
BI-4464 inhibits the PTK2 enzyme activity with an IC50 value of 2.0 nM, as evidenced by an Enzyme Assay measuring the phosphorylation of a specific substrate using a DELFIA assay. It displays strong antiproliferative activity across various human cell lines, with IC50 values ranging from 3162.28 to 7943.28 nM after six days of incubation. This compound also shows potent inhibition of human PTK2 (residues 411-689) expressed in Hi-5 cells, achieving IC50 values of 15.85 nM and 17.0 nM. Additionally, it induces PTK2 degradation in human A549 cells, with a pDC50 value greater than 10000.0. The thermodynamic solubility of BI-4464 in a phosphate buffer at pH 7 is approximately Log S = -4.19 after one hour of incubation, indicating high solubility under these conditions..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
BI-4464, a highly selective ATP-competitive inhibitor of PTK2/FAK, exhibits an IC50 of 17 nM and serves as a PTK2 ligand for PROTAC (Proteolysis Targeting Chimera).
Targets&IC50
PTK2/FAK:17 nM
Chemical Properties
Molecular Weight555.55
FormulaC28H28F3N5O4
Cas No.1227948-02-8
SmilesO(C1=C2C(CCC2=O)=CC=C1)C=3C(C(F)(F)F)=CN=C(NC4=C(OC)C=C(C(NC5CCN(C)CC5)=O)C=C4)N3
Relative Density.1.41 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 16.67 mg/mL (30.01 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8000 mL9.0001 mL18.0002 mL90.0009 mL
5 mM0.3600 mL1.8000 mL3.6000 mL18.0002 mL
10 mM0.1800 mL0.9000 mL1.8000 mL9.0001 mL
20 mM0.0900 mL0.4500 mL0.9000 mL4.5000 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BI-4464 | purchase BI-4464 | BI-4464 cost | order BI-4464 | BI-4464 chemical structure | BI-4464 formula | BI-4464 molecular weight